Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Breast Cancer Screening Advice Confusing Following Cancer Society Update, Industry Says

This article was originally published in The Gray Sheet

Executive Summary

The American Cancer Society’s Oct. 20 update to breast cancer screening guidelines for mammograms starting at age 45, rather than its prior recommendation to start at age 40, for average risk women conflicts with other groups’ recommendations, is confusing and potential “risky”, say the imaging industry and some medical groups.

You may also be interested in...



House Members Seek More Transparency, Input For US Preventive Services Task Force

House Energy and Commerce Committee members are backing legislation to foster more transparency at the US Preventive Services Task Force and more information-sharing with medical specialists prior to making recommendations, but USPSTF Chair Kirsten Bibbins-Domingo says that the task force already works with medical societies before setting guidelines for testing and treatments.

Task Force Mammography Guidelines Present Challenges And Opportunities

Mammography coverage policies among public and private payers are not likely to be restricted, at least in the near term, by the U.S. Preventive Services Task Force's new breast cancer screening guidelines, but prospects for longer-term adjustments remain

Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children

Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT034332

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel